nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—NR3C1—glaucoma	0.346	0.638	CbGaD
Betamethasone—PTGS2—glaucoma	0.196	0.362	CbGaD
Betamethasone—CYP3A4—Pilocarpine—glaucoma	0.022	0.166	CbGbCtD
Betamethasone—ABCB1—Timolol—glaucoma	0.0211	0.159	CbGbCtD
Betamethasone—ABCB1—Clonidine—glaucoma	0.0179	0.135	CbGbCtD
Betamethasone—CYP3A4—Brinzolamide—glaucoma	0.0173	0.13	CbGbCtD
Betamethasone—CYP3A4—Dorzolamide—glaucoma	0.0167	0.126	CbGbCtD
Betamethasone—CYP3A4—Methazolamide—glaucoma	0.0149	0.112	CbGbCtD
Betamethasone—CYP3A4—Acetazolamide—glaucoma	0.0119	0.0897	CbGbCtD
Betamethasone—CYP3A4—Clonidine—glaucoma	0.0107	0.0811	CbGbCtD
Betamethasone—Fluocinonide—SMO—glaucoma	0.000891	0.125	CrCbGaD
Betamethasone—Difluprednate—NR3C1—glaucoma	0.000287	0.0403	CrCbGaD
Betamethasone—Prednicarbate—NR3C1—glaucoma	0.000278	0.0391	CrCbGaD
Betamethasone—Clocortolone—NR3C1—glaucoma	0.000278	0.0391	CrCbGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000276	0.00746	CbGpPWpGaD
Betamethasone—PGR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000269	0.0073	CbGpPWpGaD
Betamethasone—Diflorasone—NR3C1—glaucoma	0.000263	0.037	CrCbGaD
Betamethasone—Desonide—NR3C1—glaucoma	0.000263	0.037	CrCbGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.00026	0.00705	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CA5A—glaucoma	0.00026	0.00703	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NARFL—glaucoma	0.00026	0.00703	CbGpPWpGaD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—glaucoma	0.000259	0.00702	CbGpPWpGaD
Betamethasone—Desoximetasone—NR3C1—glaucoma	0.000257	0.0361	CrCbGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000256	0.00694	CbGpPWpGaD
Betamethasone—Loteprednol—NR3C1—glaucoma	0.000254	0.0357	CrCbGaD
Betamethasone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00025	0.00678	CbGpPWpGaD
Betamethasone—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000247	0.00669	CbGpPWpGaD
Betamethasone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000235	0.00638	CbGpPWpGaD
Betamethasone—Flurandrenolide—NR3C1—glaucoma	0.000225	0.0316	CrCbGaD
Betamethasone—Flumethasone Pivalate—NR3C1—glaucoma	0.000221	0.0311	CrCbGaD
Betamethasone—Halobetasol Propionate—NR3C1—glaucoma	0.000218	0.0306	CrCbGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000207	0.0056	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000205	0.00556	CbGpPWpGaD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000203	0.00549	CbGpPWpGaD
Betamethasone—Amcinonide—NR3C1—glaucoma	0.000202	0.0284	CrCbGaD
Betamethasone—Budesonide—NR3C1—glaucoma	0.000202	0.0284	CrCbGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000199	0.00539	CbGpPWpGaD
Betamethasone—Fluticasone furoate—NR3C1—glaucoma	0.000198	0.0279	CrCbGaD
Betamethasone—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000193	0.00524	CbGpPWpGaD
Betamethasone—Mometasone—NR3C1—glaucoma	0.000192	0.027	CrCbGaD
Betamethasone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000191	0.00518	CbGpPWpGaD
Betamethasone—Rimexolone—NR3C1—glaucoma	0.00019	0.0267	CrCbGaD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000187	0.00506	CbGpPWpGaD
Betamethasone—Beclomethasone—NR3C1—glaucoma	0.000179	0.0252	CrCbGaD
Betamethasone—Fluocinonide—NR3C1—glaucoma	0.000179	0.0252	CrCbGaD
Betamethasone—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000177	0.00479	CbGpPWpGaD
Betamethasone—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000177	0.00478	CbGpPWpGaD
Betamethasone—Fluocinolone Acetonide—NR3C1—glaucoma	0.000174	0.0245	CrCbGaD
Betamethasone—Alclometasone—NR3C1—glaucoma	0.000174	0.0245	CrCbGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000171	0.00463	CbGpPWpGaD
Betamethasone—Flunisolide—NR3C1—glaucoma	0.00017	0.0238	CrCbGaD
Betamethasone—Fludrocortisone—NR3C1—glaucoma	0.00017	0.0238	CrCbGaD
Betamethasone—Clobetasol propionate—NR3C1—glaucoma	0.00017	0.0238	CrCbGaD
Betamethasone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000169	0.00458	CbGpPWpGaD
Betamethasone—Paramethasone—NR3C1—glaucoma	0.000168	0.0235	CrCbGaD
Betamethasone—Fluorometholone—NR3C1—glaucoma	0.000164	0.023	CrCbGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000161	0.00436	CbGpPWpGaD
Betamethasone—Methylprednisolone—NR3C1—glaucoma	0.000158	0.0222	CrCbGaD
Betamethasone—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	0.000158	0.00427	CbGpPWpGaD
Betamethasone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000153	0.00414	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.00015	0.00406	CbGpPWpGaD
Betamethasone—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000149	0.00403	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000146	0.00396	CbGpPWpGaD
Betamethasone—Fluoxymesterone—NR3C1—glaucoma	0.00014	0.0197	CrCbGaD
Betamethasone—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000135	0.00366	CbGpPWpGaD
Betamethasone—Triamcinolone—NR3C1—glaucoma	0.000133	0.0187	CrCbGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	0.000133	0.00359	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000128	0.00346	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CA1—glaucoma	0.000127	0.00343	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000123	0.00333	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CTSA—glaucoma	0.000123	0.00332	CbGpPWpGaD
Betamethasone—Prednisone—NR3C1—glaucoma	0.000121	0.017	CrCbGaD
Betamethasone—Fluticasone Propionate—NR3C1—glaucoma	0.000119	0.0167	CrCbGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000117	0.00316	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CA2—glaucoma	0.000116	0.00314	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000115	0.00312	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000115	0.00311	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000113	0.00307	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000113	0.00307	CbGpPWpGaD
Betamethasone—Hypotension—Travoprost—glaucoma	0.000112	0.000396	CcSEcCtD
Betamethasone—Shock—Pilocarpine—glaucoma	0.000112	0.000396	CcSEcCtD
Betamethasone—Prednisolone—NR3C1—glaucoma	0.000111	0.0157	CrCbGaD
Betamethasone—PGR—Signaling by ERBB4—BAD—glaucoma	0.000111	0.00301	CbGpPWpGaD
Betamethasone—Thrombocytopenia—Pilocarpine—glaucoma	0.000111	0.000394	CcSEcCtD
Betamethasone—Erythema—Clonidine—glaucoma	0.000111	0.000394	CcSEcCtD
Betamethasone—Tachycardia—Pilocarpine—glaucoma	0.000111	0.000393	CcSEcCtD
Betamethasone—Dyspepsia—Brimonidine—glaucoma	0.000111	0.000392	CcSEcCtD
Betamethasone—Hallucination—Betaxolol—glaucoma	0.00011	0.000392	CcSEcCtD
Betamethasone—Hypotension—Brinzolamide—glaucoma	0.00011	0.000391	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.00011	0.00297	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Pilocarpine—glaucoma	0.00011	0.000389	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000109	0.000388	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Travoprost—glaucoma	0.000109	0.000386	CcSEcCtD
Betamethasone—Insomnia—Dorzolamide—glaucoma	0.000109	0.000385	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000108	0.000385	CcSEcCtD
Betamethasone—Fatigue—Brimonidine—glaucoma	0.000108	0.000384	CcSEcCtD
Betamethasone—Anorexia—Pilocarpine—glaucoma	0.000108	0.000383	CcSEcCtD
Betamethasone—Feeling abnormal—Acetazolamide—glaucoma	0.000108	0.000383	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000108	0.00292	CbGpPWpGaD
Betamethasone—Paraesthesia—Dorzolamide—glaucoma	0.000108	0.000382	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000107	0.000381	CcSEcCtD
Betamethasone—Pain—Brimonidine—glaucoma	0.000107	0.000381	CcSEcCtD
Betamethasone—Visual impairment—Betaxolol—glaucoma	0.000107	0.000379	CcSEcCtD
Betamethasone—Dexamethasone—CYP1B1—glaucoma	0.000107	0.015	CrCbGaD
Betamethasone—Insomnia—Brinzolamide—glaucoma	0.000107	0.000379	CcSEcCtD
Betamethasone—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000106	0.00288	CbGpPWpGaD
Betamethasone—Hypotension—Pilocarpine—glaucoma	0.000106	0.000376	CcSEcCtD
Betamethasone—Paraesthesia—Brinzolamide—glaucoma	0.000106	0.000376	CcSEcCtD
Betamethasone—Dyspepsia—Dorzolamide—glaucoma	0.000106	0.000375	CcSEcCtD
Betamethasone—Dyspepsia—Travoprost—glaucoma	0.000105	0.000373	CcSEcCtD
Betamethasone—Asthenia—Apraclonidine—glaucoma	0.000105	0.000373	CcSEcCtD
Betamethasone—Decreased appetite—Dorzolamide—glaucoma	0.000104	0.00037	CcSEcCtD
Betamethasone—Urticaria—Acetazolamide—glaucoma	0.000104	0.000369	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—CDKN2B—glaucoma	0.000104	0.00281	CbGpPWpGaD
Betamethasone—Dyspepsia—Brinzolamide—glaucoma	0.000104	0.000368	CcSEcCtD
Betamethasone—Eye disorder—Betaxolol—glaucoma	0.000104	0.000368	CcSEcCtD
Betamethasone—Pruritus—Apraclonidine—glaucoma	0.000104	0.000367	CcSEcCtD
Betamethasone—Body temperature increased—Acetazolamide—glaucoma	0.000103	0.000367	CcSEcCtD
Betamethasone—Fatigue—Dorzolamide—glaucoma	0.000103	0.000367	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000103	0.000366	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Travoprost—glaucoma	0.000103	0.000366	CcSEcCtD
Betamethasone—Fatigue—Travoprost—glaucoma	0.000103	0.000365	CcSEcCtD
Betamethasone—Ill-defined disorder—Clonidine—glaucoma	0.000103	0.000365	CcSEcCtD
Betamethasone—Pain—Dorzolamide—glaucoma	0.000103	0.000364	CcSEcCtD
Betamethasone—Insomnia—Pilocarpine—glaucoma	0.000103	0.000364	CcSEcCtD
Betamethasone—Decreased appetite—Brinzolamide—glaucoma	0.000103	0.000364	CcSEcCtD
Betamethasone—Weight decreased—Timolol—glaucoma	0.000102	0.000363	CcSEcCtD
Betamethasone—Pain—Travoprost—glaucoma	0.000102	0.000362	CcSEcCtD
Betamethasone—Hyperglycaemia—Timolol—glaucoma	0.000102	0.000362	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000102	0.00277	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000102	0.000361	CcSEcCtD
Betamethasone—Paraesthesia—Pilocarpine—glaucoma	0.000102	0.000361	CcSEcCtD
Betamethasone—Asthenia—Bimatoprost—glaucoma	0.000102	0.000361	CcSEcCtD
Betamethasone—Fatigue—Brinzolamide—glaucoma	0.000102	0.000361	CcSEcCtD
Betamethasone—Angioedema—Clonidine—glaucoma	0.000101	0.00036	CcSEcCtD
Betamethasone—Pain—Brinzolamide—glaucoma	0.000101	0.000358	CcSEcCtD
Betamethasone—Angiopathy—Betaxolol—glaucoma	0.000101	0.000357	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000101	0.00273	CbGpPWpGaD
Betamethasone—Pruritus—Bimatoprost—glaucoma	0.0001	0.000356	CcSEcCtD
Betamethasone—Diarrhoea—Apraclonidine—glaucoma	0.0001	0.000355	CcSEcCtD
Betamethasone—Malaise—Clonidine—glaucoma	0.0001	0.000355	CcSEcCtD
Betamethasone—Dyspepsia—Pilocarpine—glaucoma	9.98e-05	0.000354	CcSEcCtD
Betamethasone—Syncope—Clonidine—glaucoma	9.95e-05	0.000353	CcSEcCtD
Betamethasone—Arrhythmia—Betaxolol—glaucoma	9.91e-05	0.000352	CcSEcCtD
Betamethasone—Feeling abnormal—Dorzolamide—glaucoma	9.89e-05	0.000351	CcSEcCtD
Betamethasone—Decreased appetite—Pilocarpine—glaucoma	9.85e-05	0.00035	CcSEcCtD
Betamethasone—Feeling abnormal—Travoprost—glaucoma	9.84e-05	0.000349	CcSEcCtD
Betamethasone—Conjunctivitis—Timolol—glaucoma	9.81e-05	0.000348	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dorzolamide—glaucoma	9.81e-05	0.000348	CcSEcCtD
Betamethasone—Alopecia—Betaxolol—glaucoma	9.8e-05	0.000348	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Pilocarpine—glaucoma	9.79e-05	0.000347	CcSEcCtD
Betamethasone—Gastrointestinal pain—Travoprost—glaucoma	9.77e-05	0.000347	CcSEcCtD
Betamethasone—Loss of consciousness—Clonidine—glaucoma	9.75e-05	0.000346	CcSEcCtD
Betamethasone—Feeling abnormal—Brinzolamide—glaucoma	9.72e-05	0.000345	CcSEcCtD
Betamethasone—Pain—Pilocarpine—glaucoma	9.69e-05	0.000344	CcSEcCtD
Betamethasone—Dizziness—Apraclonidine—glaucoma	9.68e-05	0.000343	CcSEcCtD
Betamethasone—Erythema—Betaxolol—glaucoma	9.66e-05	0.000343	CcSEcCtD
Betamethasone—Urticaria—Dorzolamide—glaucoma	9.53e-05	0.000338	CcSEcCtD
Betamethasone—Abdominal pain—Dorzolamide—glaucoma	9.48e-05	0.000337	CcSEcCtD
Betamethasone—Body temperature increased—Dorzolamide—glaucoma	9.48e-05	0.000337	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—CA5A—glaucoma	9.48e-05	0.00257	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NARFL—glaucoma	9.48e-05	0.00257	CbGpPWpGaD
Betamethasone—Abdominal pain—Travoprost—glaucoma	9.44e-05	0.000335	CcSEcCtD
Betamethasone—Anxiety—Clonidine—glaucoma	9.41e-05	0.000334	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	9.4e-05	0.00255	CbGpPWpGaD
Betamethasone—Asthenia—Acetazolamide—glaucoma	9.39e-05	0.000333	CcSEcCtD
Betamethasone—Dizziness—Bimatoprost—glaucoma	9.38e-05	0.000333	CcSEcCtD
Betamethasone—Urticaria—Brinzolamide—glaucoma	9.37e-05	0.000332	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—NGFR—glaucoma	9.37e-05	0.00254	CbGpPWpGaD
Betamethasone—Feeling abnormal—Pilocarpine—glaucoma	9.34e-05	0.000331	CcSEcCtD
Betamethasone—Discomfort—Clonidine—glaucoma	9.33e-05	0.000331	CcSEcCtD
Betamethasone—Vomiting—Apraclonidine—glaucoma	9.3e-05	0.00033	CcSEcCtD
Betamethasone—Gastrointestinal pain—Pilocarpine—glaucoma	9.27e-05	0.000329	CcSEcCtD
Betamethasone—Bradycardia—Timolol—glaucoma	9.23e-05	0.000327	CcSEcCtD
Betamethasone—Dermatitis—Apraclonidine—glaucoma	9.22e-05	0.000327	CcSEcCtD
Betamethasone—Headache—Apraclonidine—glaucoma	9.17e-05	0.000325	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—LRP12—glaucoma	9.16e-05	0.00248	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—NR3C1—glaucoma	9.12e-05	0.00247	CbGpPWpGaD
Betamethasone—Oedema—Clonidine—glaucoma	9.05e-05	0.000321	CcSEcCtD
Betamethasone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	9.03e-05	0.00245	CbGpPWpGaD
Betamethasone—Hallucination—Timolol—glaucoma	9.02e-05	0.00032	CcSEcCtD
Betamethasone—Asthenia—Brimonidine—glaucoma	9.01e-05	0.00032	CcSEcCtD
Betamethasone—Infection—Clonidine—glaucoma	8.99e-05	0.000319	CcSEcCtD
Betamethasone—Abdominal pain—Pilocarpine—glaucoma	8.96e-05	0.000318	CcSEcCtD
Betamethasone—Body temperature increased—Pilocarpine—glaucoma	8.96e-05	0.000318	CcSEcCtD
Betamethasone—Ill-defined disorder—Betaxolol—glaucoma	8.96e-05	0.000318	CcSEcCtD
Betamethasone—Diarrhoea—Acetazolamide—glaucoma	8.96e-05	0.000318	CcSEcCtD
Betamethasone—Rash—Bimatoprost—glaucoma	8.95e-05	0.000317	CcSEcCtD
Betamethasone—Dermatitis—Bimatoprost—glaucoma	8.94e-05	0.000317	CcSEcCtD
Betamethasone—Shock—Clonidine—glaucoma	8.91e-05	0.000316	CcSEcCtD
Betamethasone—Pruritus—Brimonidine—glaucoma	8.89e-05	0.000315	CcSEcCtD
Betamethasone—Headache—Bimatoprost—glaucoma	8.89e-05	0.000315	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	8.88e-05	0.00241	CbGpPWpGaD
Betamethasone—Nervous system disorder—Clonidine—glaucoma	8.88e-05	0.000315	CcSEcCtD
Betamethasone—Thrombocytopenia—Clonidine—glaucoma	8.86e-05	0.000315	CcSEcCtD
Betamethasone—Tachycardia—Clonidine—glaucoma	8.84e-05	0.000314	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	8.83e-05	0.00239	CbGpPWpGaD
Betamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	8.77e-05	0.00238	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Clonidine—glaucoma	8.75e-05	0.000311	CcSEcCtD
Betamethasone—Visual impairment—Timolol—glaucoma	8.73e-05	0.00031	CcSEcCtD
Betamethasone—Malaise—Betaxolol—glaucoma	8.71e-05	0.000309	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	8.69e-05	0.00235	CbGpPWpGaD
Betamethasone—Nausea—Apraclonidine—glaucoma	8.69e-05	0.000308	CcSEcCtD
Betamethasone—Vertigo—Betaxolol—glaucoma	8.68e-05	0.000308	CcSEcCtD
Betamethasone—Syncope—Betaxolol—glaucoma	8.66e-05	0.000307	CcSEcCtD
Betamethasone—Dizziness—Acetazolamide—glaucoma	8.66e-05	0.000307	CcSEcCtD
Betamethasone—Anorexia—Clonidine—glaucoma	8.63e-05	0.000306	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—GSTM1—glaucoma	8.61e-05	0.00233	CbGpPWpGaD
Betamethasone—Asthenia—Dorzolamide—glaucoma	8.61e-05	0.000305	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	8.6e-05	0.00233	CbGpPWpGaD
Betamethasone—Asthenia—Travoprost—glaucoma	8.57e-05	0.000304	CcSEcCtD
Betamethasone—Hydrocortisone—NR3C1—glaucoma	8.52e-05	0.012	CrCbGaD
Betamethasone—NR3C1—Adipogenesis—FAS—glaucoma	8.52e-05	0.00231	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	8.5e-05	0.0023	CbGpPWpGaD
Betamethasone—Pruritus—Dorzolamide—glaucoma	8.49e-05	0.000301	CcSEcCtD
Betamethasone—Loss of consciousness—Betaxolol—glaucoma	8.49e-05	0.000301	CcSEcCtD
Betamethasone—Eye disorder—Timolol—glaucoma	8.47e-05	0.000301	CcSEcCtD
Betamethasone—Asthenia—Brinzolamide—glaucoma	8.46e-05	0.0003	CcSEcCtD
Betamethasone—Hypotension—Clonidine—glaucoma	8.46e-05	0.0003	CcSEcCtD
Betamethasone—Pruritus—Travoprost—glaucoma	8.45e-05	0.0003	CcSEcCtD
Betamethasone—Nausea—Bimatoprost—glaucoma	8.43e-05	0.000299	CcSEcCtD
Betamethasone—Pruritus—Brinzolamide—glaucoma	8.34e-05	0.000296	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	8.32e-05	0.00225	CbGpPWpGaD
Betamethasone—Vomiting—Acetazolamide—glaucoma	8.32e-05	0.000295	CcSEcCtD
Betamethasone—Dizziness—Brimonidine—glaucoma	8.31e-05	0.000295	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	8.26e-05	0.00224	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Clonidine—glaucoma	8.25e-05	0.000293	CcSEcCtD
Betamethasone—Angiopathy—Timolol—glaucoma	8.22e-05	0.000292	CcSEcCtD
Betamethasone—Myalgia—Betaxolol—glaucoma	8.22e-05	0.000292	CcSEcCtD
Betamethasone—Diarrhoea—Dorzolamide—glaucoma	8.21e-05	0.000291	CcSEcCtD
Betamethasone—Headache—Acetazolamide—glaucoma	8.2e-05	0.000291	CcSEcCtD
Betamethasone—Anxiety—Betaxolol—glaucoma	8.19e-05	0.000291	CcSEcCtD
Betamethasone—Insomnia—Clonidine—glaucoma	8.19e-05	0.000291	CcSEcCtD
Betamethasone—Diarrhoea—Travoprost—glaucoma	8.17e-05	0.00029	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—TXN—glaucoma	8.17e-05	0.00221	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—BDNF—glaucoma	8.15e-05	0.00221	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	8.15e-05	0.00221	CbGpPWpGaD
Betamethasone—Asthenia—Pilocarpine—glaucoma	8.13e-05	0.000289	CcSEcCtD
Betamethasone—Paraesthesia—Clonidine—glaucoma	8.13e-05	0.000288	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	8.13e-05	0.0022	CbGpPWpGaD
Betamethasone—Discomfort—Betaxolol—glaucoma	8.12e-05	0.000288	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.12e-05	0.0022	CbGpPWpGaD
Betamethasone—Arrhythmia—Timolol—glaucoma	8.1e-05	0.000287	CcSEcCtD
Betamethasone—Diarrhoea—Brinzolamide—glaucoma	8.07e-05	0.000286	CcSEcCtD
Betamethasone—Pruritus—Pilocarpine—glaucoma	8.02e-05	0.000285	CcSEcCtD
Betamethasone—Alopecia—Timolol—glaucoma	8.01e-05	0.000284	CcSEcCtD
Betamethasone—Dizziness—Dorzolamide—glaucoma	7.93e-05	0.000282	CcSEcCtD
Betamethasone—Rash—Brimonidine—glaucoma	7.92e-05	0.000281	CcSEcCtD
Betamethasone—Dermatitis—Brimonidine—glaucoma	7.91e-05	0.000281	CcSEcCtD
Betamethasone—Dizziness—Travoprost—glaucoma	7.9e-05	0.00028	CcSEcCtD
Betamethasone—Erythema—Timolol—glaucoma	7.89e-05	0.00028	CcSEcCtD
Betamethasone—Oedema—Betaxolol—glaucoma	7.88e-05	0.00028	CcSEcCtD
Betamethasone—Headache—Brimonidine—glaucoma	7.87e-05	0.000279	CcSEcCtD
Betamethasone—Decreased appetite—Clonidine—glaucoma	7.87e-05	0.000279	CcSEcCtD
Betamethasone—Infection—Betaxolol—glaucoma	7.83e-05	0.000278	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—IL1A—glaucoma	7.83e-05	0.00212	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Clonidine—glaucoma	7.82e-05	0.000277	CcSEcCtD
Betamethasone—Fatigue—Clonidine—glaucoma	7.81e-05	0.000277	CcSEcCtD
Betamethasone—Dizziness—Brinzolamide—glaucoma	7.8e-05	0.000277	CcSEcCtD
Betamethasone—Nausea—Acetazolamide—glaucoma	7.77e-05	0.000276	CcSEcCtD
Betamethasone—Diarrhoea—Pilocarpine—glaucoma	7.76e-05	0.000275	CcSEcCtD
Betamethasone—Shock—Betaxolol—glaucoma	7.75e-05	0.000275	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—CDKN1B—glaucoma	7.74e-05	0.0021	CbGpPWpGaD
Betamethasone—Pain—Clonidine—glaucoma	7.74e-05	0.000275	CcSEcCtD
Betamethasone—Nervous system disorder—Betaxolol—glaucoma	7.73e-05	0.000274	CcSEcCtD
Betamethasone—Thrombocytopenia—Betaxolol—glaucoma	7.72e-05	0.000274	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	7.71e-05	0.00209	CbGpPWpGaD
Betamethasone—Tachycardia—Betaxolol—glaucoma	7.69e-05	0.000273	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL1A—glaucoma	7.65e-05	0.00207	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	7.63e-05	0.00207	CbGpPWpGaD
Betamethasone—Vomiting—Dorzolamide—glaucoma	7.63e-05	0.000271	CcSEcCtD
Betamethasone—Hyperhidrosis—Betaxolol—glaucoma	7.62e-05	0.00027	CcSEcCtD
Betamethasone—Triamcinolone—PTGS2—glaucoma	7.57e-05	0.0106	CrCbGaD
Betamethasone—Rash—Dorzolamide—glaucoma	7.56e-05	0.000268	CcSEcCtD
Betamethasone—Dermatitis—Dorzolamide—glaucoma	7.56e-05	0.000268	CcSEcCtD
Betamethasone—Rash—Travoprost—glaucoma	7.53e-05	0.000267	CcSEcCtD
Betamethasone—Dermatitis—Travoprost—glaucoma	7.53e-05	0.000267	CcSEcCtD
Betamethasone—Headache—Dorzolamide—glaucoma	7.52e-05	0.000267	CcSEcCtD
Betamethasone—Anorexia—Betaxolol—glaucoma	7.51e-05	0.000267	CcSEcCtD
Betamethasone—Vomiting—Brinzolamide—glaucoma	7.5e-05	0.000266	CcSEcCtD
Betamethasone—Dizziness—Pilocarpine—glaucoma	7.5e-05	0.000266	CcSEcCtD
Betamethasone—Headache—Travoprost—glaucoma	7.48e-05	0.000266	CcSEcCtD
Betamethasone—Nausea—Brimonidine—glaucoma	7.46e-05	0.000265	CcSEcCtD
Betamethasone—Feeling abnormal—Clonidine—glaucoma	7.46e-05	0.000265	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.45e-05	0.00202	CbGpPWpGaD
Betamethasone—Rash—Brinzolamide—glaucoma	7.44e-05	0.000264	CcSEcCtD
Betamethasone—Dermatitis—Brinzolamide—glaucoma	7.43e-05	0.000264	CcSEcCtD
Betamethasone—Gastrointestinal pain—Clonidine—glaucoma	7.4e-05	0.000263	CcSEcCtD
Betamethasone—Headache—Brinzolamide—glaucoma	7.39e-05	0.000262	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.38e-05	0.002	CbGpPWpGaD
Betamethasone—Hypotension—Betaxolol—glaucoma	7.36e-05	0.000261	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	7.34e-05	0.00199	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	7.33e-05	0.00198	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.3e-05	0.00198	CbGpPWpGaD
Betamethasone—Angioedema—Timolol—glaucoma	7.21e-05	0.000256	CcSEcCtD
Betamethasone—Vomiting—Pilocarpine—glaucoma	7.21e-05	0.000256	CcSEcCtD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.21e-05	0.00195	CbGpPWpGaD
Betamethasone—Urticaria—Clonidine—glaucoma	7.19e-05	0.000255	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Betaxolol—glaucoma	7.18e-05	0.000255	CcSEcCtD
Betamethasone—Abdominal pain—Clonidine—glaucoma	7.16e-05	0.000254	CcSEcCtD
Betamethasone—Body temperature increased—Clonidine—glaucoma	7.16e-05	0.000254	CcSEcCtD
Betamethasone—Rash—Pilocarpine—glaucoma	7.15e-05	0.000254	CcSEcCtD
Betamethasone—Dermatitis—Pilocarpine—glaucoma	7.14e-05	0.000253	CcSEcCtD
Betamethasone—Insomnia—Betaxolol—glaucoma	7.13e-05	0.000253	CcSEcCtD
Betamethasone—Nausea—Dorzolamide—glaucoma	7.13e-05	0.000253	CcSEcCtD
Betamethasone—Headache—Pilocarpine—glaucoma	7.1e-05	0.000252	CcSEcCtD
Betamethasone—Nausea—Travoprost—glaucoma	7.1e-05	0.000252	CcSEcCtD
Betamethasone—Vertigo—Timolol—glaucoma	7.09e-05	0.000252	CcSEcCtD
Betamethasone—Paraesthesia—Betaxolol—glaucoma	7.08e-05	0.000251	CcSEcCtD
Betamethasone—Syncope—Timolol—glaucoma	7.08e-05	0.000251	CcSEcCtD
Betamethasone—Nausea—Brinzolamide—glaucoma	7.01e-05	0.000249	CcSEcCtD
Betamethasone—Dyspepsia—Betaxolol—glaucoma	6.94e-05	0.000246	CcSEcCtD
Betamethasone—Loss of consciousness—Timolol—glaucoma	6.93e-05	0.000246	CcSEcCtD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	6.9e-05	0.00187	CbGpPWpGaD
Betamethasone—Decreased appetite—Betaxolol—glaucoma	6.85e-05	0.000243	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—FAS—glaucoma	6.82e-05	0.00185	CbGpPWpGaD
Betamethasone—Hypertension—Timolol—glaucoma	6.81e-05	0.000242	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Betaxolol—glaucoma	6.8e-05	0.000241	CcSEcCtD
Betamethasone—Fatigue—Betaxolol—glaucoma	6.8e-05	0.000241	CcSEcCtD
Betamethasone—Pain—Betaxolol—glaucoma	6.74e-05	0.000239	CcSEcCtD
Betamethasone—Nausea—Pilocarpine—glaucoma	6.73e-05	0.000239	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.73e-05	0.00182	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—C3—glaucoma	6.72e-05	0.00182	CbGpPWpGaD
Betamethasone—Myalgia—Timolol—glaucoma	6.72e-05	0.000238	CcSEcCtD
Betamethasone—Anxiety—Timolol—glaucoma	6.69e-05	0.000238	CcSEcCtD
Betamethasone—Discomfort—Timolol—glaucoma	6.64e-05	0.000235	CcSEcCtD
Betamethasone—Asthenia—Clonidine—glaucoma	6.5e-05	0.00023	CcSEcCtD
Betamethasone—Feeling abnormal—Betaxolol—glaucoma	6.5e-05	0.00023	CcSEcCtD
Betamethasone—Oedema—Timolol—glaucoma	6.44e-05	0.000228	CcSEcCtD
Betamethasone—Anaphylactic shock—Timolol—glaucoma	6.44e-05	0.000228	CcSEcCtD
Betamethasone—Pruritus—Clonidine—glaucoma	6.41e-05	0.000227	CcSEcCtD
Betamethasone—Infection—Timolol—glaucoma	6.4e-05	0.000227	CcSEcCtD
Betamethasone—Dexamethasone—NR3C1—glaucoma	6.35e-05	0.00892	CrCbGaD
Betamethasone—PGR—Signaling Pathways—OPN4—glaucoma	6.35e-05	0.00172	CbGpPWpGaD
Betamethasone—Shock—Timolol—glaucoma	6.33e-05	0.000225	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GSTT1—glaucoma	6.33e-05	0.00172	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NARFL—glaucoma	6.33e-05	0.00172	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA5A—glaucoma	6.33e-05	0.00172	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	6.33e-05	0.00171	CbGpPWpGaD
Betamethasone—Nervous system disorder—Timolol—glaucoma	6.31e-05	0.000224	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	6.29e-05	0.0017	CbGpPWpGaD
Betamethasone—Urticaria—Betaxolol—glaucoma	6.26e-05	0.000222	CcSEcCtD
Betamethasone—Body temperature increased—Betaxolol—glaucoma	6.23e-05	0.000221	CcSEcCtD
Betamethasone—Hyperhidrosis—Timolol—glaucoma	6.22e-05	0.000221	CcSEcCtD
Betamethasone—Diarrhoea—Clonidine—glaucoma	6.19e-05	0.00022	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	6.16e-05	0.00167	CbGpPWpGaD
Betamethasone—Anorexia—Timolol—glaucoma	6.14e-05	0.000218	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.06e-05	0.00164	CbGpPWpGaD
Betamethasone—Hypotension—Timolol—glaucoma	6.02e-05	0.000213	CcSEcCtD
Betamethasone—Dizziness—Clonidine—glaucoma	5.99e-05	0.000212	CcSEcCtD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	5.95e-05	0.00161	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.92e-05	0.0016	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HEYL—glaucoma	5.9e-05	0.0016	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	5.89e-05	0.00159	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Timolol—glaucoma	5.87e-05	0.000208	CcSEcCtD
Betamethasone—Insomnia—Timolol—glaucoma	5.82e-05	0.000207	CcSEcCtD
Betamethasone—Paraesthesia—Timolol—glaucoma	5.78e-05	0.000205	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	5.76e-05	0.00156	CbGpPWpGaD
Betamethasone—Vomiting—Clonidine—glaucoma	5.76e-05	0.000204	CcSEcCtD
Betamethasone—PTGS2—Disease—LRP12—glaucoma	5.73e-05	0.00155	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTGFR—glaucoma	5.72e-05	0.00155	CbGpPWpGaD
Betamethasone—Rash—Clonidine—glaucoma	5.71e-05	0.000203	CcSEcCtD
Betamethasone—Dermatitis—Clonidine—glaucoma	5.7e-05	0.000202	CcSEcCtD
Betamethasone—Headache—Clonidine—glaucoma	5.67e-05	0.000201	CcSEcCtD
Betamethasone—Dyspepsia—Timolol—glaucoma	5.67e-05	0.000201	CcSEcCtD
Betamethasone—Asthenia—Betaxolol—glaucoma	5.66e-05	0.000201	CcSEcCtD
Betamethasone—Decreased appetite—Timolol—glaucoma	5.6e-05	0.000199	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.58e-05	0.00151	CbGpPWpGaD
Betamethasone—Pruritus—Betaxolol—glaucoma	5.58e-05	0.000198	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Timolol—glaucoma	5.56e-05	0.000197	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—NR3C1—glaucoma	5.55e-05	0.0015	CbGpPWpGaD
Betamethasone—Fatigue—Timolol—glaucoma	5.55e-05	0.000197	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.54e-05	0.0015	CbGpPWpGaD
Betamethasone—Pain—Timolol—glaucoma	5.51e-05	0.000195	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.5e-05	0.00149	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	5.45e-05	0.00148	CbGpPWpGaD
Betamethasone—Diarrhoea—Betaxolol—glaucoma	5.39e-05	0.000191	CcSEcCtD
Betamethasone—Nausea—Clonidine—glaucoma	5.38e-05	0.000191	CcSEcCtD
Betamethasone—Feeling abnormal—Timolol—glaucoma	5.31e-05	0.000188	CcSEcCtD
Betamethasone—Gastrointestinal pain—Timolol—glaucoma	5.27e-05	0.000187	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—glaucoma	5.23e-05	0.00142	CbGpPWpGaD
Betamethasone—Dizziness—Betaxolol—glaucoma	5.21e-05	0.000185	CcSEcCtD
Betamethasone—Urticaria—Timolol—glaucoma	5.12e-05	0.000182	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.11e-05	0.00138	CbGpPWpGaD
Betamethasone—Body temperature increased—Timolol—glaucoma	5.09e-05	0.000181	CcSEcCtD
Betamethasone—Abdominal pain—Timolol—glaucoma	5.09e-05	0.000181	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—ABCA1—glaucoma	5.05e-05	0.00137	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP1B1—glaucoma	5.05e-05	0.00137	CbGpPWpGaD
Betamethasone—Vomiting—Betaxolol—glaucoma	5.01e-05	0.000178	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—CDKN2B—glaucoma	5e-05	0.00135	CbGpPWpGaD
Betamethasone—Rash—Betaxolol—glaucoma	4.97e-05	0.000176	CcSEcCtD
Betamethasone—Dermatitis—Betaxolol—glaucoma	4.97e-05	0.000176	CcSEcCtD
Betamethasone—Headache—Betaxolol—glaucoma	4.94e-05	0.000175	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.74e-05	0.00128	CbGpPWpGaD
Betamethasone—Nausea—Betaxolol—glaucoma	4.68e-05	0.000166	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—CA1—glaucoma	4.63e-05	0.00125	CbGpPWpGaD
Betamethasone—Asthenia—Timolol—glaucoma	4.62e-05	0.000164	CcSEcCtD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	4.61e-05	0.00125	CbGpPWpGaD
Betamethasone—Pruritus—Timolol—glaucoma	4.56e-05	0.000162	CcSEcCtD
Betamethasone—ABCB1—Metabolism—CA5A—glaucoma	4.49e-05	0.00122	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NARFL—glaucoma	4.49e-05	0.00122	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CTSA—glaucoma	4.48e-05	0.00121	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RPTOR—glaucoma	4.47e-05	0.00121	CbGpPWpGaD
Betamethasone—Diarrhoea—Timolol—glaucoma	4.41e-05	0.000156	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—NR3C1—glaucoma	4.39e-05	0.00119	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NCK2—glaucoma	4.33e-05	0.00117	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.29e-05	0.00116	CbGpPWpGaD
Betamethasone—Dizziness—Timolol—glaucoma	4.26e-05	0.000151	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	4.25e-05	0.00115	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CA2—glaucoma	4.23e-05	0.00115	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	4.15e-05	0.00113	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.14e-05	0.00112	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.14e-05	0.00112	CbGpPWpGaD
Betamethasone—Vomiting—Timolol—glaucoma	4.09e-05	0.000145	CcSEcCtD
Betamethasone—Rash—Timolol—glaucoma	4.06e-05	0.000144	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.06e-05	0.0011	CbGpPWpGaD
Betamethasone—Dermatitis—Timolol—glaucoma	4.06e-05	0.000144	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GSTM1—glaucoma	4.03e-05	0.00109	CbGpPWpGaD
Betamethasone—Headache—Timolol—glaucoma	4.03e-05	0.000143	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.96e-05	0.00107	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.95e-05	0.00107	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.93e-05	0.00106	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.9e-05	0.00106	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—glaucoma	3.85e-05	0.00104	CbGpPWpGaD
Betamethasone—Nausea—Timolol—glaucoma	3.82e-05	0.000136	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	3.74e-05	0.00101	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HEYL—glaucoma	3.69e-05	0.001	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR1OP—glaucoma	3.69e-05	0.001	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HDAC9—glaucoma	3.68e-05	0.000998	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.67e-05	0.000995	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	3.66e-05	0.000991	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.65e-05	0.000988	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—glaucoma	3.62e-05	0.000979	CbGpPWpGaD
Betamethasone—Dexamethasone—PTGS2—glaucoma	3.6e-05	0.00506	CrCbGaD
Betamethasone—PLA2G1B—Metabolism—MTHFR—glaucoma	3.56e-05	0.000965	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.38e-05	0.000914	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.36e-05	0.000911	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—APOE—glaucoma	3.32e-05	0.000899	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CAV1—glaucoma	3.29e-05	0.000891	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	3.21e-05	0.000869	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.14e-05	0.000852	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	3.13e-05	0.000846	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.1e-05	0.00084	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA1—glaucoma	3.09e-05	0.000838	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CDKN2B—glaucoma	3.05e-05	0.000825	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CTSA—glaucoma	3e-05	0.000811	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TXN—glaucoma	2.98e-05	0.000808	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—glaucoma	2.96e-05	0.000802	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—glaucoma	2.89e-05	0.000784	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMO—glaucoma	2.88e-05	0.000781	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.88e-05	0.000779	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA2—glaucoma	2.83e-05	0.000766	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.83e-05	0.000765	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA5A—glaucoma	2.77e-05	0.000749	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NARFL—glaucoma	2.77e-05	0.000749	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.76e-05	0.000749	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.76e-05	0.000749	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.72e-05	0.000737	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.7e-05	0.00073	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.69e-05	0.000728	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NR3C1—glaucoma	2.67e-05	0.000724	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK2—glaucoma	2.64e-05	0.000714	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—glaucoma	2.61e-05	0.000707	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.51e-05	0.000681	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NOS3—glaucoma	2.49e-05	0.000673	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.48e-05	0.000671	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.35e-05	0.000637	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTT1—glaucoma	2.31e-05	0.000626	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HDAC9—glaucoma	2.3e-05	0.000624	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—glaucoma	2.27e-05	0.000616	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NGFR—glaucoma	2.26e-05	0.000613	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA1—glaucoma	2.19e-05	0.000594	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK1—glaucoma	2.15e-05	0.000582	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CTSA—glaucoma	2.12e-05	0.000575	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.12e-05	0.000573	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.01e-05	0.000546	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA2—glaucoma	2.01e-05	0.000543	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2e-05	0.000543	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TXN—glaucoma	1.99e-05	0.00054	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN2B—glaucoma	1.98e-05	0.000536	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EDN1—glaucoma	1.9e-05	0.000515	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.86e-05	0.000505	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCA1—glaucoma	1.84e-05	0.000499	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1B1—glaucoma	1.84e-05	0.000499	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.82e-05	0.000492	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.8e-05	0.000488	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.78e-05	0.000481	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CDKN2B—glaucoma	1.76e-05	0.000477	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NGF—glaucoma	1.75e-05	0.000473	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.67e-05	0.000451	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—C3—glaucoma	1.66e-05	0.00045	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—glaucoma	1.55e-05	0.000419	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTT1—glaucoma	1.55e-05	0.000418	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CAV1—glaucoma	1.53e-05	0.000415	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—glaucoma	1.47e-05	0.000399	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FN1—glaucoma	1.46e-05	0.000395	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BAD—glaucoma	1.44e-05	0.00039	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.43e-05	0.000387	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TXN—glaucoma	1.41e-05	0.000383	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA1—glaucoma	1.35e-05	0.000366	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CTSA—glaucoma	1.31e-05	0.000354	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—glaucoma	1.3e-05	0.000353	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.26e-05	0.000341	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—glaucoma	1.24e-05	0.000336	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA2—glaucoma	1.24e-05	0.000335	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCA1—glaucoma	1.23e-05	0.000333	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1B1—glaucoma	1.23e-05	0.000333	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—glaucoma	1.21e-05	0.000328	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAV1—glaucoma	1.2e-05	0.000325	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOS3—glaucoma	1.16e-05	0.000314	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—glaucoma	1.1e-05	0.000297	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—glaucoma	1.04e-05	0.000281	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—glaucoma	1e-05	0.000272	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—glaucoma	9.84e-06	0.000267	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—glaucoma	9.67e-06	0.000262	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CAV1—glaucoma	9.58e-06	0.000259	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—glaucoma	9.29e-06	0.000252	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NOS3—glaucoma	9.08e-06	0.000246	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BAD—glaucoma	9.01e-06	0.000244	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCA1—glaucoma	8.73e-06	0.000236	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1B1—glaucoma	8.73e-06	0.000236	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TXN—glaucoma	8.7e-06	0.000236	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—glaucoma	8.7e-06	0.000236	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—glaucoma	8.34e-06	0.000226	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—glaucoma	8.3e-06	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—glaucoma	8.1e-06	0.000219	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAV1—glaucoma	8.02e-06	0.000217	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS3—glaucoma	7.24e-06	0.000196	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—glaucoma	6.98e-06	0.000189	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—glaucoma	6.75e-06	0.000183	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—glaucoma	6.3e-06	0.000171	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—glaucoma	6.28e-06	0.00017	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—glaucoma	6.17e-06	0.000167	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NOS3—glaucoma	6.07e-06	0.000164	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—glaucoma	5.74e-06	0.000155	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAV1—glaucoma	5.69e-06	0.000154	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1B1—glaucoma	5.38e-06	0.000146	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCA1—glaucoma	5.38e-06	0.000146	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NOS3—glaucoma	4.3e-06	0.000116	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—glaucoma	4.3e-06	0.000116	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—glaucoma	3.93e-06	0.000107	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—glaucoma	3.8e-06	0.000103	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—glaucoma	3.54e-06	9.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAV1—glaucoma	3.5e-06	9.49e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NOS3—glaucoma	2.65e-06	7.18e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—glaucoma	2.42e-06	6.56e-05	CbGpPWpGaD
